APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Cabazitaxel

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Types
Purity above 99% · Other Purity
Applications
Age Below 65 · Age Above 65

5 editions20 December 2025

View 5 research editions

Pharma & Healthcare

Swine Reproductive and Respiratory Syndrome Vaccine

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Types
Active Vaccine · Inactivated Vaccines
Applications
Government Tender · Market Sales

5 editions31 December 2025

View 5 research editions
APO Research, Inc.